Affinity of anti-spike antibodies to three major SARS-CoV-2 variants in recipients of three major vaccines

BACKGROUND: Measuring anti-viral antibody affinity in blood plasma or serum is a rational quantitative approach to assess humoral immune response and acquired protection. Three common vaccines against SARS-CoV-2—Comirnaty developed by Pfizer/BioNTech, Spikevax developed by Moderna/NIAID, and Jcovden...

Descripción completa

Detalles Bibliográficos
Autores principales: Macdonald, Patrick J., Schaub, Jeffrey M., Ruan, Qiaoqiao, Williams, Carroll L., Prostko, John C., Tetin, Sergey Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403978/
https://www.ncbi.nlm.nih.gov/pubmed/36034646
http://dx.doi.org/10.1038/s43856-022-00174-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403978/
https://www.ncbi.nlm.nih.gov/pubmed/36034646
http://dx.doi.org/10.1038/s43856-022-00174-9

Ejemplares similares